Health
As variants threaten Covid-19 progress, US weighs trial results of Johnson & Johnson vaccine candidate – CNN International
As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight,…
(CNN)As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight, despite trial reports showing apparently lower efficacy rates than two vaccines already authorized in the US.
Johnson & Johnson’s single-shot coronavirus vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial and 85% effective against severe disease, the company announced Friday. It…
-
General23 hours agoChris Bowen must be sobbing over Albanese’s AI deal
-
Noosa News15 hours agoThe Latest Trailer for ‘Squid Game’ Season Three Is Here — and “No Matter How You Look at It, Life Is Just Unfair”
-
Noosa News16 hours agoComing Soon: The Malibu Barbie Cafe Is Popping Up in Australia for the First Time, Complete with a Cocktail-Slinging Ken-Themed Bar
-
Business7 hours agoLeading brokers name 3 ASX shares to buy today 16 June 2025